9 completed. 9 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Completed 9 |
Follow selexipag: new trials by email Literature Review of selexipag trials Research Report on selexipag
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bioequivalence Study to Compare Selexipag 400 Microgram Film Coated Tablets Versus Uptravi® (Selexipag) 400 Microgram Film Coated Tablets Selexipag Film Coated Tablets (T1), Selexipag Film Coated Tablets (T2), Uptravi® (selexipag) film coated tablets - Arterial Hypertension (PAH) | Phase 1 | Completed | Humanis Saglık Anonim Sirketi | 30 | 2026-04-08 | 2026-07-09 |
| Bioequivalence Study to Compare Selexipag 400mcg Film Coated Tablets (400 mcg Selexipag) Versus Uptravi® 400mcg Film Coated Tablets (400 mcg Selexipag) Selexipag Film Coated Tablets, Uptravi® Film Coated Tablets - Pulmonary Arterial Hypertension (PAH) | Phase 1 | Completed | Humanis Saglık Anonim Sirketi | 14 | 2025-01-09 | 2025-04-22 |
| A Clinical Study to Assess the Effect of Clopidogrel on the Pharmacokinetics of Selexipag and Its Active Metabolite in Healthy Male Subjects Selexipag, Clopidogrel - Healthy Subjects | Phase 1 | Completed | Actelion | 22 | 2018-03-05 | 2025-06-22 |
| Potential Pharmacokinetic Interaction Between Selexipag and Midazolam in Healthy Male Subjects Midazolam, Selexipag - Healthy Subjects | Phase 1 | Completed | Actelion | 20 | 2016-07-01 | 2016-10-13 |
| A Clinical Study to Investigate the Effect of Gemfibrozil or Rifampicin on Blood Concentrations of Selexipag in Healthy Subjects Selexipag, Gemfibrozil, Rifampicin - Healthy Subjects | Phase 1 | Completed | Actelion | 40 | 2016-06-01 | 2025-02-03 |
| Comparison of Two Dose Strengths of Selexipag in Healthy Adults Selexipag (adult formulation), Selexipag (pediatric formulation) - Healthy Subjects | Phase 1 | Completed | Actelion | 20 | 2016-06-01 | 2025-02-03 |
| Absolute Bioavailability of a Single Oral Dose of Selexipag in Healthy Subjects Selexipag for intravenous use, Selexipag for oral use - Healthy Subjects | Phase 1 | Completed | Actelion | 19 | 2015-01-01 | 2025-02-03 |
| Study in Healthy Male Subjects to Demonstrate Bioequivalence of 1600 μg Selexipag Administered as Eight Tablets of 200 μg or as Single Tablet of 1600 μg selexipag - Bioequivalence | Phase 1 | Completed | Actelion | 80 | 2012-09-01 | 2025-02-03 |
| Study of Selexipag and Its Metabolite ACT-333679 on Cardiac Repolarization in Healthy Male and Female Subjects selexipag, placebo for selexipag, moxifloxacin - Cardiodynamics, Safety | Phase 1 | Completed | Actelion | 159 | 2012-06-01 | 2014-08-01 |
Hypertension (1) · Pulmonary Arterial Hypertension (1)
Actelion (7) · Humanis Saglık Anonim Sirketi (2)
Belgium (1) · France (1) · India (1) · Jordan (1) · United States (1)
Daniela Baldoni, PhD, PharmD (1) · Margaux Boehler (1) · Matthias Hoch, PhD (1) · Pierre-Eric Juif, PhD (1) · Priska Kaufmann, PhD (1) · Shirin Bruderer (1) · Shirin Bruderer, PhD (1)
PMID 27885399, PMID 28639216, PMID 28715853, PMID 32415684
2016 (2)